LogicBio Therapeutics, Inc. Variable Lease, Cost
LogicBio Therapeutics, Inc. reported Variable Lease, Cost of $231.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2022-11-14
- LogicBio Therapeutics, Inc. variable lease, cost for the quarter ending 2022-09-30 was $231.00K, a 11.06% increase year-over-year.
- LogicBio Therapeutics, Inc. variable lease, cost for the quarter ending 2022-06-30 was $215.00K, a 0.46% decline year-over-year.
- LogicBio Therapeutics, Inc. variable lease, cost for the quarter ending 2022-03-31 was $223.00K, a 3.72% increase year-over-year.
- LogicBio Therapeutics, Inc. variable lease, cost for the quarter ending 2021-12-31 was $216.00K, a 16.13% increase year-over-year.
- LogicBio Therapeutics, Inc. variable lease, cost for fiscal 2021 was $855.00K, a 29.55% increase from fiscal 2020.
- LogicBio Therapeutics, Inc. variable lease, cost for fiscal 2020 was $660.00K, a 100.00% increase from fiscal 2019.
- LogicBio Therapeutics, Inc. variable lease, cost for fiscal 2019 was $330.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2022-09-30 | $231.00K 10-Q · filed 2022-11-14 | $446.00K derived: sum of 2 quarters · filed 2022-11-14 | $669.00K 10-Q · filed 2022-11-14 | $885.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | $215.00K 10-Q · filed 2022-08-15 | $438.00K 10-Q · filed 2022-08-15 | $654.00K derived: sum of 3 quarters · filed 2022-08-15 | $862.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-03-31 | $223.00K 10-Q · filed 2022-05-16 | $439.00K derived: sum of 2 quarters · filed 2022-05-16 | $647.00K derived: sum of 3 quarters · filed 2022-11-14 | $863.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-12-31 | $216.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $424.00K derived: sum of 2 quarters · filed 2022-11-14 | $640.00K derived: sum of 3 quarters · filed 2022-11-14 | $855.00K 10-K · filed 2022-03-04 |
| 2021-09-30 | $208.00K 10-Q · filed 2022-11-14 | $424.00K derived: sum of 2 quarters · filed 2022-11-14 | $639.00K 10-Q · filed 2022-11-14 | $825.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $216.00K 10-Q · filed 2022-08-15 | $431.00K 10-Q · filed 2022-08-15 | $617.00K derived: sum of 3 quarters · filed 2022-08-15 | $807.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $215.00K 10-Q · filed 2022-05-16 | $401.00K derived: sum of 2 quarters · filed 2022-05-16 | $591.00K derived: sum of 3 quarters · filed 2022-05-16 | $777.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $186.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $376.00K derived: sum of 2 quarters · filed 2022-03-04 | $562.00K derived: sum of 3 quarters · filed 2022-03-04 | $660.00K 10-K · filed 2022-03-04 |
| 2020-09-30 | $190.00K 10-Q · filed 2021-11-15 | $376.00K derived: sum of 2 quarters · filed 2021-11-15 | $474.00K 10-Q · filed 2021-11-15 | $570.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $186.00K 10-Q · filed 2021-08-09 | $284.00K 10-Q · filed 2021-08-09 | $380.00K derived: sum of 3 quarters · filed 2021-08-09 | $480.00K derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $98.00K 10-Q · filed 2021-05-10 | $194.00K derived: sum of 2 quarters · filed 2021-05-10 | $294.00K derived: sum of 3 quarters · filed 2021-05-10 | $386.00K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $196.00K derived: sum of 2 quarters · filed 2021-03-15 | $288.00K derived: sum of 3 quarters · filed 2021-03-15 | $330.00K 10-K · filed 2021-03-15 |
| 2019-09-30 | $100.00K 10-Q · filed 2020-11-09 | $192.00K derived: sum of 2 quarters · filed 2020-11-09 | $234.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $92.00K 10-Q · filed 2020-08-10 | $134.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $42.00K 10-Q · filed 2020-05-11 |